+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Vaccine Research Market 2024-2028

  • PDF Icon

    Report

  • 170 Pages
  • August 2024
  • Region: Global
  • TechNavio
  • ID: 5606360
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The vaccine research market is forecasted to grow by USD 21.4 billion during 2023-2028, accelerating at a CAGR of 10.84% during the forecast period. The report on the vaccine research market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high prevalence of infectious diseases, need for novel vaccines for chronic infections, and adjuvants and vaccine delivery systems.

The vaccine research market is segmented as below:

By End-user

  • Public
  • Private

By Age Group

  • Pediatric
  • Adult

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the adoption of ai to speed up R&D of vaccines as one of the prime reasons driving the vaccine research market growth during the next few years. Also, fluctuations in demand for vaccines in high-income and developing countries and rising R&D of novel vaccines will lead to sizable demand in the market.

The report on the vaccine research market covers the following areas:

  • Vaccine research market sizing
  • Vaccine research market forecast
  • Vaccine research market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading vaccine research market vendors that include Abbott Laboratories, Astellas Pharma Inc., AstraZeneca Plc, Bavarian Nordic AS, Bharat Biotech Ltd., CanSino Biologics Inc., Creative Biogene, CSL Ltd., Daiichi Sankyo Co. Ltd., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Merck and Co. Inc., Moderna Inc., Novavax Inc., Panacea Biotec Ltd., Pfizer Inc., Sanofi SA, Serum Institute of India Pvt. Ltd., and Takeda Pharmaceutical Co. Ltd. Also, the vaccine research market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Market Segmentation by Age Group
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ billion)
Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Vaccine Research Market 2018 - 2022
Historic Market Size - Data Table on Global Vaccine Research Market 2018 - 2022 ($ billion)
4.2 End-user segment analysis 2018 - 2022
Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
4.3 Age Group segment analysis 2018 - 2022
Historic Market Size - Age Group Segment 2018 - 2022 ($ billion)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by End-user
6.1 Market segments
Chart on End-user - Market share 2023-2028 (%)
Data Table on End-user - Market share 2023-2028 (%)
6.2 Comparison by End-user
Chart on Comparison by End-user
Data Table on Comparison by End-user
6.3 Public - Market size and forecast 2023-2028
Chart on Public - Market size and forecast 2023-2028 ($ billion)
Data Table on Public - Market size and forecast 2023-2028 ($ billion)
Chart on Public - Year-over-year growth 2023-2028 (%)
Data Table on Public - Year-over-year growth 2023-2028 (%)
6.4 Private - Market size and forecast 2023-2028
Chart on Private - Market size and forecast 2023-2028 ($ billion)
Data Table on Private - Market size and forecast 2023-2028 ($ billion)
Chart on Private - Year-over-year growth 2023-2028 (%)
Data Table on Private - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by End-user
Market opportunity by End-user ($ billion)
Data Table on Market opportunity by End-user ($ billion)
7 Market Segmentation by Age Group
7.1 Market segments
Chart on Age Group - Market share 2023-2028 (%)
Data Table on Age Group - Market share 2023-2028 (%)
7.2 Comparison by Age Group
Chart on Comparison by Age Group
Data Table on Comparison by Age Group
7.3 Pediatric - Market size and forecast 2023-2028
Chart on Pediatric - Market size and forecast 2023-2028 ($ billion)
Data Table on Pediatric - Market size and forecast 2023-2028 ($ billion)
Chart on Pediatric - Year-over-year growth 2023-2028 (%)
Data Table on Pediatric - Year-over-year growth 2023-2028 (%)
7.4 Adult - Market size and forecast 2023-2028
Chart on Adult - Market size and forecast 2023-2028 ($ billion)
Data Table on Adult - Market size and forecast 2023-2028 ($ billion)
Chart on Adult - Year-over-year growth 2023-2028 (%)
Data Table on Adult - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Age Group
Market opportunity by Age Group ($ billion)
Data Table on Market opportunity by Age Group ($ billion)
8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ billion)
Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ billion)
Data Table on US - Market size and forecast 2023-2028 ($ billion)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ billion)
Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ billion)
Data Table on China - Market size and forecast 2023-2028 ($ billion)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.11 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ billion)
Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints
11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business
12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 Abbott Laboratories
Abbott Laboratories - Overview
Abbott Laboratories - Business segments
Abbott Laboratories - Key news
Abbott Laboratories - Key offerings
Abbott Laboratories - Segment focus
12.4 Astellas Pharma Inc.
Astellas Pharma Inc. - Overview
Astellas Pharma Inc. - Product/Service
Astellas Pharma Inc. - Key news
Astellas Pharma Inc. - Key offerings
12.5 AstraZeneca Plc
AstraZeneca Plc - Overview
AstraZeneca Plc - Product/Service
AstraZeneca Plc - Key news
AstraZeneca Plc - Key offerings
12.6 Bavarian Nordic AS
Bavarian Nordic AS - Overview
Bavarian Nordic AS - Product/Service
Bavarian Nordic AS - Key news
Bavarian Nordic AS - Key offerings
12.7 Bharat Biotech Ltd.
Bharat Biotech Ltd. - Overview
Bharat Biotech Ltd. - Product/Service
Bharat Biotech Ltd. - Key offerings
12.8 CanSino Biologics Inc.
CanSino Biologics Inc. - Overview
CanSino Biologics Inc. - Product/Service
CanSino Biologics Inc. - Key news
CanSino Biologics Inc. - Key offerings
12.9 CSL Ltd.
CSL Ltd. - Overview
CSL Ltd. - Business segments
CSL Ltd. - Key news
CSL Ltd. - Key offerings
CSL Ltd. - Segment focus
12.10 Daiichi Sankyo Co. Ltd.
Daiichi Sankyo Co. Ltd. - Overview
Daiichi Sankyo Co. Ltd. - Product/Service
Daiichi Sankyo Co. Ltd. - Key news
Daiichi Sankyo Co. Ltd. - Key offerings
12.11 Emergent BioSolutions Inc.
Emergent BioSolutions Inc. - Overview
Emergent BioSolutions Inc. - Product/Service
Emergent BioSolutions Inc. - Key offerings
12.12 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
12.13 Johnson and Johnson Services Inc.
Johnson and Johnson Services Inc. - Overview
Johnson and Johnson Services Inc. - Business segments
Johnson and Johnson Services Inc. - Key news
Johnson and Johnson Services Inc. - Key offerings
Johnson and Johnson Services Inc. - Segment focus
12.14 Merck and Co. Inc.
Merck and Co. Inc. - Overview
Merck and Co. Inc. - Business segments
Merck and Co. Inc. - Key news
Merck and Co. Inc. - Key offerings
Merck and Co. Inc. - Segment focus
12.15 Novavax Inc.
Novavax Inc. - Overview
Novavax Inc. - Product/Service
Novavax Inc. - Key offerings
12.16 Panacea Biotec Ltd.
Panacea Biotec Ltd. - Overview
Panacea Biotec Ltd. - Product/Service
Panacea Biotec Ltd. - Key news
Panacea Biotec Ltd. - Key offerings
12.17 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product/Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 6: Executive Summary - Chart on Market Segmentation by Age Group
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Company Market Positioning
Exhibits 10: Parent Market
Exhibits 11: Data Table on - Parent Market
Exhibits 12: Market characteristics analysis
Exhibits 13: Value Chain Analysis
Exhibits 14: Offerings of companies included in the market definition
Exhibits 15: Market segments
Exhibits 16: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits 17: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits 18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 20: Historic Market Size - Data Table on Global Vaccine Research Market 2018 - 2022 ($ billion)
Exhibits 21: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
Exhibits 22: Historic Market Size - Age Group Segment 2018 - 2022 ($ billion)
Exhibits 23: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits 24: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits 25: Five forces analysis - Comparison between 2023 and 2028
Exhibits 26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 31: Chart on Market condition - Five forces 2023 and 2028
Exhibits 32: Chart on End-user - Market share 2023-2028 (%)
Exhibits 33: Data Table on End-user - Market share 2023-2028 (%)
Exhibits 34: Chart on Comparison by End-user
Exhibits 35: Data Table on Comparison by End-user
Exhibits 36: Chart on Public - Market size and forecast 2023-2028 ($ billion)
Exhibits 37: Data Table on Public - Market size and forecast 2023-2028 ($ billion)
Exhibits 38: Chart on Public - Year-over-year growth 2023-2028 (%)
Exhibits 39: Data Table on Public - Year-over-year growth 2023-2028 (%)
Exhibits 40: Chart on Private - Market size and forecast 2023-2028 ($ billion)
Exhibits 41: Data Table on Private - Market size and forecast 2023-2028 ($ billion)
Exhibits 42: Chart on Private - Year-over-year growth 2023-2028 (%)
Exhibits 43: Data Table on Private - Year-over-year growth 2023-2028 (%)
Exhibits 44: Market opportunity by End-user ($ billion)
Exhibits 45: Data Table on Market opportunity by End-user ($ billion)
Exhibits 46: Chart on Age Group - Market share 2023-2028 (%)
Exhibits 47: Data Table on Age Group - Market share 2023-2028 (%)
Exhibits 48: Chart on Comparison by Age Group
Exhibits 49: Data Table on Comparison by Age Group
Exhibits 50: Chart on Pediatric - Market size and forecast 2023-2028 ($ billion)
Exhibits 51: Data Table on Pediatric - Market size and forecast 2023-2028 ($ billion)
Exhibits 52: Chart on Pediatric - Year-over-year growth 2023-2028 (%)
Exhibits 53: Data Table on Pediatric - Year-over-year growth 2023-2028 (%)
Exhibits 54: Chart on Adult - Market size and forecast 2023-2028 ($ billion)
Exhibits 55: Data Table on Adult - Market size and forecast 2023-2028 ($ billion)
Exhibits 56: Chart on Adult - Year-over-year growth 2023-2028 (%)
Exhibits 57: Data Table on Adult - Year-over-year growth 2023-2028 (%)
Exhibits 58: Market opportunity by Age Group ($ billion)
Exhibits 59: Data Table on Market opportunity by Age Group ($ billion)
Exhibits 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 61: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 62: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 63: Chart on Geographic comparison
Exhibits 64: Data Table on Geographic comparison
Exhibits 65: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits 66: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits 67: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 68: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 69: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits 70: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits 71: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 72: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 73: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits 74: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits 75: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 76: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 77: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits 78: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits 79: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 80: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 81: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits 82: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits 83: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 84: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 85: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits 86: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits 87: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 88: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 89: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits 90: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits 91: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 92: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 93: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits 94: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits 95: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 96: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 97: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits 98: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits 99: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 100: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 101: Market opportunity By Geographical Landscape ($ billion)
Exhibits 102: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits 103: Impact of drivers and challenges in 2023 and 2028
Exhibits 104: Overview on criticality of inputs and factors of differentiation
Exhibits 105: Overview on factors of disruption
Exhibits 106: Impact of key risks on business
Exhibits 107: Companies covered
Exhibits 108: Matrix on companies position and classification
Exhibits 109: Abbott Laboratories - Overview
Exhibits 110: Abbott Laboratories - Business segments
Exhibits 111: Abbott Laboratories - Key news
Exhibits 112: Abbott Laboratories - Key offerings
Exhibits 113: Abbott Laboratories - Segment focus
Exhibits 114: Astellas Pharma Inc. - Overview
Exhibits 115: Astellas Pharma Inc. - Product/Service
Exhibits 116: Astellas Pharma Inc. - Key news
Exhibits 117: Astellas Pharma Inc. - Key offerings
Exhibits 118: AstraZeneca Plc - Overview
Exhibits 119: AstraZeneca Plc - Product/Service
Exhibits 120: AstraZeneca Plc - Key news
Exhibits 121: AstraZeneca Plc - Key offerings
Exhibits 122: Bavarian Nordic AS - Overview
Exhibits 123: Bavarian Nordic AS - Product/Service
Exhibits 124: Bavarian Nordic AS - Key news
Exhibits 125: Bavarian Nordic AS - Key offerings
Exhibits 126: Bharat Biotech Ltd. - Overview
Exhibits 127: Bharat Biotech Ltd. - Product/Service
Exhibits 128: Bharat Biotech Ltd. - Key offerings
Exhibits 129: CanSino Biologics Inc. - Overview
Exhibits 130: CanSino Biologics Inc. - Product/Service
Exhibits 131: CanSino Biologics Inc. - Key news
Exhibits 132: CanSino Biologics Inc. - Key offerings
Exhibits 133: CSL Ltd. - Overview
Exhibits 134: CSL Ltd. - Business segments
Exhibits 135: CSL Ltd. - Key news
Exhibits 136: CSL Ltd. - Key offerings
Exhibits 137: CSL Ltd. - Segment focus
Exhibits 138: Daiichi Sankyo Co. Ltd. - Overview
Exhibits 139: Daiichi Sankyo Co. Ltd. - Product/Service
Exhibits 140: Daiichi Sankyo Co. Ltd. - Key news
Exhibits 141: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits 142: Emergent BioSolutions Inc. - Overview
Exhibits 143: Emergent BioSolutions Inc. - Product/Service
Exhibits 144: Emergent BioSolutions Inc. - Key offerings
Exhibits 145: GlaxoSmithKline Plc - Overview
Exhibits 146: GlaxoSmithKline Plc - Business segments
Exhibits 147: GlaxoSmithKline Plc - Key news
Exhibits 148: GlaxoSmithKline Plc - Key offerings
Exhibits 149: GlaxoSmithKline Plc - Segment focus
Exhibits 150: Johnson and Johnson Services Inc. - Overview
Exhibits 151: Johnson and Johnson Services Inc. - Business segments
Exhibits 152: Johnson and Johnson Services Inc. - Key news
Exhibits 153: Johnson and Johnson Services Inc. - Key offerings
Exhibits 154: Johnson and Johnson Services Inc. - Segment focus
Exhibits 155: Merck and Co. Inc. - Overview
Exhibits 156: Merck and Co. Inc. - Business segments
Exhibits 157: Merck and Co. Inc. - Key news
Exhibits 158: Merck and Co. Inc. - Key offerings
Exhibits 159: Merck and Co. Inc. - Segment focus
Exhibits 160: Novavax Inc. - Overview
Exhibits 161: Novavax Inc. - Product/Service
Exhibits 162: Novavax Inc. - Key offerings
Exhibits 163: Panacea Biotec Ltd. - Overview
Exhibits 164: Panacea Biotec Ltd. - Product/Service
Exhibits 165: Panacea Biotec Ltd. - Key news
Exhibits 166: Panacea Biotec Ltd. - Key offerings
Exhibits 167: Pfizer Inc. - Overview
Exhibits 168: Pfizer Inc. - Product/Service
Exhibits 169: Pfizer Inc. - Key news
Exhibits 170: Pfizer Inc. - Key offerings
Exhibits 171: Inclusions checklist
Exhibits 172: Exclusions checklist
Exhibits 173: Currency conversion rates for US$
Exhibits 174: Research methodology
Exhibits 175: Information sources
Exhibits 176: Data validation
Exhibits 177: Validation techniques employed for market sizing
Exhibits 178: Data synthesis
Exhibits 179: 360 degree market analysis
Exhibits 180: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the vaccine research market: Abbott Laboratories, Astellas Pharma Inc., AstraZeneca PLC, Bavarian Nordic AS, Bharat Biotech Ltd., CanSino Biologics Inc., Creative Biogene, CSL Ltd., Daiichi Sankyo Co. Ltd., Emergent BioSolutions Inc., GlaxoSmithKline PLC, Johnson and Johnson Services Inc., Merck and Co. Inc., Moderna Inc., Novavax Inc., Panacea Biotec Ltd., Pfizer Inc., Sanofi SA, Serum Institute of India Pvt. Ltd., and Takeda Pharmaceutical Co. Ltd..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is adoption of AI to speed up R&D of vaccines."

According to the report, one of the major drivers for this market is the high prevalence of infectious diseases.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Astellas Pharma Inc.
  • AstraZeneca Plc
  • Bavarian Nordic AS
  • Bharat Biotech Ltd.
  • CanSino Biologics Inc.
  • Creative Biogene
  • CSL Ltd.
  • Daiichi Sankyo Co. Ltd.
  • Emergent BioSolutions Inc.
  • GlaxoSmithKline Plc
  • Johnson and Johnson Services Inc.
  • Merck and Co. Inc.
  • Moderna Inc.
  • Novavax Inc.
  • Panacea Biotec Ltd.
  • Pfizer Inc.
  • Sanofi SA
  • Serum Institute of India Pvt. Ltd.
  • Takeda Pharmaceutical Co. Ltd.